Boston Heart Lab, a Framingham, MA-based provider of cardiovascular care management products and services, has raised $10 million in an equity and rights financing, according to an SEC filing. Company CEO Susan Hertzberg was not available for comment at her office today. The company’s website lists two members of the investment team at Boston-based Bain Capital Ventures—Jeff Crisan and Alice Limkakeng—as directors of the company. Peter Parker, the former CEO of Cambridge, MA-based Cequent Pharmaceuticals (now part of Marina Biotech of Bothell, WA), is listed as Boston Heart Lab’s chairman. Boston Heat Lab says it provides a proprietary lab tests to measure patients’ cholesterol as well as programs to track the health of people with cardiovascular disease.